tiprankstipranks
Renovaro Biosciences (RENB)
NASDAQ:RENB

Renovaro Biosciences (RENB) Income Statement

105 Followers

Renovaro Biosciences Income Statement

Last quarter (Q ), Renovaro Biosciences's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Renovaro Biosciences's net income was $-4.53M. See Renovaro Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ 360.61K$ 352.70K$ 2.96K-$ 0.00$ 0.00
Cost of Revenue
--$ -4.03M-$ 0.00$ 0.00
Gross Profit
$ 360.61K$ 352.70K$ 2.96K-$ 0.00$ 0.00
Operating Expense
$ 40.15M$ 38.56M$ 22.83M$ 23.40M$ 11.92M$ 10.99M
Operating Income
$ -21.19M$ -38.56M$ -22.83M$ -23.40M$ -11.92M$ -10.99M
Net Non Operating Interest Income Expense
$ -957.06K$ -706.96K$ 2.65M$ -3.41M$ -53.98K$ 73.44K
Other Income Expense
$ 120.02K$ 419.18K$ -18.17K-$ 561.39K$ -7.10M
Pretax Income
$ -41.23M$ -39.68M$ -113.43M$ -26.85M$ -11.42M$ -18.02M
Tax Provision
$ -70.34M$ -70.34M$ 34.00$ -125.28K$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -41.23M$ -39.68M$ -113.43M$ -26.72M$ -11.42M$ -18.02M
Basic EPS
$ -0.92$ -0.71--$ -0.25$ -0.48
Diluted EPS
$ -0.92$ -0.71-$ -0.57$ -0.25$ -0.48
Basic Average Shares
$ 186.60M$ 56.27M-$ 47.17M$ 46.33M$ 37.55M
Diluted Average Shares
$ 186.60M$ 56.27M-$ 47.17M$ 46.33M$ 37.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 40.15M$ 38.56M$ 22.83M$ 23.40M$ 11.92M$ 10.99M
Net Income From Continuing And Discontinued Operation
$ -41.23M$ -39.68M$ -113.43M$ -26.72M$ -11.42M$ -18.02M
Normalized Income
$ -88.15M$ -91.07M--$ -11.98M$ -10.92M
Interest Expense
----$ 104.28K$ 43.00
EBIT
$ -40.28M$ -38.98M$ -113.06M$ -26.47M$ -11.31M$ -18.02M
EBITDA
$ -39.60M$ -38.51M$ -112.64M$ -26.05M$ -10.95M$ -17.94M
Currency in USD

Renovaro Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis